Currently active notices of funding opportunities (NOFOs) for neuroscience research include the following requests for applications (RFAs), program announcements (PAs), and PAs with special reviews (PARs), as well as notices (NOTs), including notices of special interest (NOSIs).
NOFOs on which NICHD is the primary sponsor
- NOT-HD-22-036 Notice of Intent to Publish a NOFO for ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
- NOT-HD-21-026 NOSI: Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth
- NOT-HD-21-025 NOSI: Reproductive Health, Pregnancy, and Parenting Among Women with Disabilities
- NOT-HD-20-032 NOSI: Using Systems Science Methodologies to Protect and Improve Child and Reproductive Population Health
- NOT-HD-20-009 Notice of Interest in Advancing Research on FMR1-Associated Conditions
- PAR-23-131 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
- PAR-23-130 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
- PAR-23-075 Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
- PAR-23-074 In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
- PAR-22-215 Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
- PAR-21-355 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 Clinical Trial Optional)
- PAR-21-354 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 Clinical Trial Optional)
- PAR-21-353 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 Clinical Trial Optional)
- PAR-21-229 Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)
- PAR-21-115 Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
- PAR-20-065 Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 Clinical Trial Not Allowed)
- RFA-HD-24-004 Opportunities for Advancing Limb Regeneration Research (R01 Clinical Trial Not Allowed)
NOFOs on which NICHD is a partner
- NOT-EB-21-008 Notice of NIH Participation in the National Robotics Initiative
- NOT-HD-22-027 Notice of NICHD Participation in NOT-MH-20-110, “Collaborative Research in Computational Neuroscience (CRCNS) National Science Foundation Innovative Approaches to Science and Engineering Research on Brain Function" (apply via NSF 20-609)
- NOT-MD-19-001 NOSI: Research on the Health of Sexual and Gender Minority (SGM) Populations
- NOT-NS-22-003 NOSI: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders
- NOT-OD-21-087 NOSI: Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being
- PA-21-201 Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
- PA-21-200 Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
- PA-21-199 Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
- PAR-22-100 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
- PAR-21-342 Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)
- PAR-21-319 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
- PAR-21-311 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trial Optional)
In addition, neuroscience researchers may also be interested in NOFOs for the following NIH-wide initiatives in which NICHD participates:
- Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative
- Helping to End Addiction Long-termSM (HEAL) Initiative
- INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
- NIH Blueprint for Neuroscience Research
- NIH Strategic Response to COVID-19 Research
BACK TO TOP